drugset / Trial / NCT04085653

Managed Access Programs for BYL719, Alpelisib

NCT04085653 ↗

Expanded access Available Novartis Pharmaceuticals

Summary

The purpose of this registration is to list Managed Access Programs (MAPs) related to BYL719, Alpelisib

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Background Alpelisib Small molecule — —